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Glaucoma encompasses a group of neurodegenerative 
disorders, which involves apoptotic death of retinal ganglion 
cells (RGCs). Retinal ganglion cell degeneration inevitably 
causes atrophy of the optic nerve and progressive visual field 
damage leading to irreversible vision loss [1,2]. A recent 
survey by Tham et al. estimated that worldwide 64.3 million 
people 40–80 years old have glaucoma, which will increase 
to 76.0 million in 2020 and 111.8 million in 2040. Primary 
open angle glaucoma (POAG) is the most common type of 
glaucoma with a higher prevalence in individuals of African 
ancestry. In contrast to European or African populations, 
primary angle closure (PACG) is the leading cause of bilateral 
blindness in East Asian populations [3-5].
In open angle and closed angle glaucoma, individuals 
often remain unaware they have the disorder until advanced 
visual loss has occurred due to the degeneration of the RGCs 
[6]. RGC death and damage to the optic nerve are related 
to an imbalance between the secretion and drainage of the 
aqueous humor produced in the posterior chamber of the eye 
by the ciliary body and drained into the anterior chamber 
of the eye. Due to this imbalance, the increased intraocular 
pressure (IOP) of the eye can cause mechanical stress to 
the posterior structures of the eye, remarkably the lamina 
cribrosa and adjacent tissues [7]. Stress induced by IOP might 
result in compression, deformation, and remodeling of the 
lamina cribrosa with consequent mechanical axonal damage 
and disruption of axonal transport [8,9].
Pseudoexfoliative glaucoma (PEXG) is a major type 
of secondary glaucoma, characterized by the production, 
aggregation, and accumulation of abnormal extracellular 
fibrillar material in the anterior segment of the eye [10]. 
PEXG is a secondary type of OAG, and in this case, pigment 
and abnormal basement membrane material from the anterior 
segment of the eye is deposited in the trabecular meshwork 
(TM), and because of malfunction of the TM, an increase in 
IOP occurs and causes damage to RGCs similar to POAG. 
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Purpose: Despite the different etiology of primary open angle glaucoma (POAG), primary angle closure glaucoma 
(PACG), and pseudoexfoliative glaucoma (PEXG), several studies have suggested that these forms of glaucoma have 
overlapping genetic risk factors. Therefore, the aim of this study was to evaluate the role of genetic variants recently 
associated with POAG in different types of glaucoma in Pakistani POAG, PACG, and PEXG patient cohorts.
Methods: Six variants in CDKN2B-AS1 (rs4977756), CDKN2B (rs1063192), ATOH7 (rs1900004), CAV1 (rs4236601), 
TMCO1 (rs4656461), and SIX1 (rs10483727) were genotyped using TaqMan assays. A total of 513 unrelated patients with 
glaucoma (268 with POAG, 125 with PACG, and 120 with PEXG) and 233 healthy controls were included in the study. 
Genotypic and allelic associations were analyzed with a chi-square test.
Results: The frequency of the G allele of TMCO1 rs4656461 was significantly lower in the patients with POAG (p=0.003; 
OR [odds ratio]=0.57), PACG (p=0.009; OR=0.52), and PEXG (p=0.01; OR=0.54) compared to the control individuals. 
The T allele of ATOH7 rs1900004 was observed less frequently in the patients with PACG (p=0.03; OR=0.69) compared 
to the control individuals. The A allele of CAV1 rs4236601 was found more frequently in the patients with POAG 
(p=0.008; OR=1.49) compared to the control individuals. This study demonstrates that the TMCO1 rs4656461 variant 
is associated with POAG, PACG and PEXG in the Pakistani population. Our study was unable to confirm previous as-
sociations reported for variants in CDKN2B-AS1, CDKN2B, and SIX1 with any type of glaucoma.
Conclusions: In conclusion, we found consistent evidence of the significant association of three common variants in 
TMCO1, ATOH7, and CAV1.
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The deposition of pseudoexfoliative material also affects the 
cornea and the lens, and results in a significant loss in the 
number of axons. Oxidative stress caused by reactive oxygen 
species (ROS) is important in POAG and PEXG [11,12]. Izotti 
et al. observed that in POAG and PEXG oxidative damage 
arising from mitochondrial failure plays a role in the func-
tional decay of the TM [13].
Glaucoma is a complex disease influenced by a combi-
nation of genetic and environmental risk factors. Recently, 
several genome-wide association studies (GWASs) have 
been performed for POAG, which revealed several genetic 
variants associated with the disease. Among them are 
variants in or near the cyclin-dependent kinase inhibitor 
2B antisense RNA (CDKN2B-AS1; OMIM: 613149) gene, 
the CDKN2B gene (OMIM: 613149) , the transmembrane 
and coiled-coil domains 1 (TMCO1; OMIM: 614123) gene 
[14,15], the caveolin 1 (CAV1; OMIM: 601047) and caveolin 
2 (CAV2; OMIM: 601048) genes [16], the SIX homeobox 1 
(SIX1; OMIM:601205) gene [17,18], and the Atonal homolog 
7 (ATOH7; OMIM: 609875) gene [19].
Despite the different etiology of POAG, PACG, and 
PEXG, several studies have suggested that these forms of 
glaucoma have overlapping genetic risk factors [20,21]. 
Therefore, the aim of the current study was to evaluate the 
role of the genetic variants recently associated with POAG, in 
different types of glaucoma in Pakistani patient cohorts with 
POAG, PACG, and PEXG.
METHODS
Patients and clinical data: The present case-control study 
included 513 patients with glaucoma (268 with POAG, 125 
with PACG, 120 with PEXG) and 233 ethnically-matched 
healthy controls. Patients were recruited from the Al-Shifa 
Trust Eye Hospital in Rawalpindi, Pakistan. Complete 
ophthalmic examinations were performed for the patients and 
controls. Briefly, for the patients with POAG the inclusion 
criteria were IOP (>21 mmHg) measured using Goldmann 
applanation tonometry, a cup-to-disc ratio (CDR) >0.7 with 
thinning or notching of the disc rim, and nerve fiber layer 
defects. Visual field defects typical of glaucoma such as 
arcuate scotoma, nasal step, paracentral scotoma, and gener-
alized depression were determined with a Humphrey Field 
Analyzer (Zeiss Humphrey Systems, Dublin, CA), and an 
open anterior chamber angle was confirmed with gonioscopy. 
Only individuals affected with advanced primary open angle 
glaucoma were included in the study while patients with 
normal tension glaucoma were excluded. The presence of 
symptoms such as eye pain, headache, blurred vision, and 
vomiting with a history of colored haloes suggested PACG. 
On ocular examination, conjunctival congestion, a mid-
dilated unreactive pupil, corneal edema and a gonioscopically 
closed anterior chamber angle (presenting eye), and occlud-
able angles (fellow eye in unilateral cases) were imperative 
for diagnosis of PACG. PEXG was diagnosed in patients who 
presented with an accumulation of microfibrillar deposits 
or exfoliative material on the pupillary ruff, a clear annular 
zone, or flakes of exfoliative material with a grayish central 
disc on the anterior lens capsule, iris, or corneal endothelium 
in one or both eyes. Controls and cases were matched for age, 
gender, and ethnicity. The same detailed ophthalmological 
examination was performed for the controls as for the patients 
with glaucoma, and only control individuals without eye 
disease were selected.
Genomic DNA and genotyping: The current study was 
approved by the institutional review board of the Al-Shifa Eye 
Trust Hospital and adhered to the tenets of the Declaration 
of Helsinki. Whole-blood samples of patients and controls 
were drawn after written informed consent was obtained. 
Briefly white blood cells were lysed, followed by digestion 
of proteins, extraction of the DNA with phenol-chloroform, 
and precipitation of DNA with absolute ethanol. Genomic 
DNA was obtained from peripheral blood leukocytes using a 
standard phenol chloroform extraction method [22].
Molecular genetic analysis: Six single nucleotide polymor-
phism (SNPs: CDKN2B-AS1 rs4977756, CDKN2B rs1063192, 
ATOH7 rs1900004, CAV1 rs4236601, TMCO1 rs4656461, 
SIX1 rs10483727) were genotyped using TaqMan assays in 
an ABI PRISM 7900 real-time sequence detection system 
(Applied Biosystems, Foster City, CA), with 384-well 
microtiter plates. The 384-well plates contained 5 µl of final 
volume for each reaction in every well consisting of 2.5 μl 
TaqMan Universal PCR Master Mix (Applied Biosystems), 
0.6 μl of each primer, and 10 ng of genomic DNA. The PCR 
cycling conditions were an initial denaturation step at 95 °C 
for 12 min and 40 cycles of 92 °C for 15 s and 60 °C for 1 min. 
Fluorescent signals were measured at 60 °C. The genotype 
of each sample was determined by measuring allele-specific 
fluorescence using SDS 2.3 software for allelic discrimina-
tion (Roche, Foster City, CA). The concordance for duplicate 
samples included in the 384-well plates was >97%.
Statistical analysis: The detected genotypes of the six SNPs 
were assessed for Hardy–Weinberg equilibrium (HWE) using 
the Pearson chi-square (χ2) test. The difference between 
the genotype frequencies in the patients and controls was 
analyzed by computing the χ2 and the odds ratio (OR, 95% 
confidence interval [CI]) using the statistical software Stat-
Calc EpiInfo package v.6 (Atlanta, GA).
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RESULTS
The patients with POAG had a mean age of 54.6±1.4 years 
(52% male and 48% female), the patients with PACG had a 
mean age of 53.6±1.5 years (48.8% male, 51.2% female), the 
patients with PEXG had a mean age 52.4±2.6 years (49% 
male, 51% female), and the control subjects had a mean age 
of 54.1±1.3 years (49.5% male, 50.5% female). The p values 
for the age and gender differences were >0.05. Association 
of genotype and allele frequencies of six polymorphisms 
with different forms of glaucoma was determined. Genotype 
frequencies of all tested polymorphisms were in Hardy–
Weinberg equilibrium.
Overall, a highly significant (p<0.001) protective effect 
of the AG genotype of rs4656461 in the TMCO1 gene was 
observed for glaucoma (Table 1). The association remained 
significant when the data were grouped based on the type 
of glaucoma (POAG, p=0.005; PACG, p=0.02; PEXG, 
p=0.03; Table 2). The frequency of the minor allele G was 
significantly lower in the patients with POAG (p=0.003; 
OR=0.57 [95% CI=0.38–0.89]), PACG (p=0.009; OR=0.52 
[95% CI=0.30–0.88]), and PEXG (p=0.01; OR=0.54 [95% 
CI=0.32–0.98]) compared to the controls (Table 3). Therefore, 
the G allele may be protective for the disease.
The homozygous AA genotype of CAV1 rs4236601 was 
significantly associated with glaucoma (p=0.02, OR=2.46 
[95% CI=1.01–6.24]). When grouped by glaucoma type, the 
AA genotype of the CAV1 SNP was significantly associ-
ated with POAG (p=0.02), but not with PACG and PEXG. 
A significant difference was found for the minor allele (A) 
frequency of rs4236601 between the controls and the patients 
with POAG only (p=0.008; OR=1.49 [95% CI=1.09–2.04]; 
Table 2).
A significant difference in genotype and allele frequen-
cies was observed between the patients with PACG and 
the controls for the ATOH7 SNP rs1900004 (p=0.03; Table 
2 and Table 3). The minor allele (T) was protective for the 
disease (OR=0.69 [95% CI=0.48–1.00]). No significant 
difference in genotype and allele frequencies was observed 
for the rs49777756 polymorphism in the CDKN2B-AS1 gene, 
rs1063192 in CDKN2B, and rs10483727 in SIX1, between the 
controls and the patients with glaucoma.
DISCUSSION
In the current study, we identified an association of the 
ATOH7 polymorphism rs1900004 with the PACG type of 
glaucoma. To the best of our knowledge, this is the first study 
in which an association of an SNP in ATOH7 was determined 
in patients with PACG. In a previous study, only patients 
with POAG were genotyped, and a marginal association was 
observed [16]. ATOH7 is involved in the development of the 
eye, and it has been reported that targeted deletion of ATOH7 
causes optic nerve agenesis in mice [23]. The rs1900004 SNP 
in ATOH7 has also been associated with other eye diseases 
such as optic nerve hypoplasia [24,25].
The CAV1 SNP rs4236601 was associated with the 
POAG type of glaucoma in the current Pakistani patient 
cohort. The results of present study are consistent with a 
previous study by Thorleifsson et al. in which the A allele was 
associated with POAG susceptibility in Icelandic, Australian, 
and Chinese populations [16]. The minor allele frequencies 
identified in the Icelandic population (POAG 28.7%, controls 
22.8%) are similar to those observed in this study in the Paki-
stani population (POAG 26.3%, controls 19.3%).
However, in a study of a U.S. population, no association 
was observed with the CAV1 variant (POAG 28.5%, controls 
26.9%) [26]. No association was observed with PACG and 
PEXG glaucoma in the present study, which is in agreement 
with negative findings for PEXG in Icelandic and Swedish 
cohorts [16]. In a meta-analysis performed by Huang et al. 
[27], allele A in rs4236601 SNP was a significant risk factor 
in POAG p<0.001; [OR=1.23; 95% CI, 1.12–1.34]. Upon the 
stratification of data for ethnicity, the A allele conferred a 
higher disease risk among Caucasians (p<0.001 [OR=1.25; 
95% CI, 1.18–1.33]) and Asians (p=0.003 [OR=3.33; 95% CI, 
1.56–7.08]). The findings of the current study also support 
the results of meta-analysis since the A allele is signifi-
cantly associated with POAG (p=0.008 [OR=1.49; 95% CI, 
1.09–2.04]).
CAV1 is involved in regulating endothelial nitric oxide 
synthase (eNOS), an enzyme that produces nitric oxide, and 
transforming growth factor beta (TGF-β). eNOS is involved in 
regulating blood flow to ocular tissues and nitric oxide levels 
in plasma [28]. Excessive production of nitric oxide causes 
cytotoxicity, neurodegeneration, and apoptotic cell death 
[29,30]. Therefore, a functional change in CAV1 might cause 
an imbalance in eNOS levels that could potentially result in 
RGC degeneration, an important process in glaucoma.
We observed a significant association of the TMCO1 
gene polymorphism rs4656461 in Pakistani patients with 
POAG, PACG, and PEXG. In previous studies, a higher 
frequency of the G allele was found in patients compared 
to controls of Australian and European descent, whereas in 
the present study the A allele was found more frequently in 
the patients compared to the controls [14,15]. The contradic-
tory association observed for this variant in the TMCO1 
gene suggests that either the G allele has a different effect in 
different populations, possibly due to the involvement of other 
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contributing factors, or that it might be in linkage disequi-
librium with a yet unidentified causative variant in or near 
the TMCO1 gene. The rs4656461 polymorphism is located 
downstream of the TMCO1 gene [14,15] in the same linkage 
disequilibrium block as a second polymorphism, rs7518099, 
located within intron 2 of TMCO1, which has been associated 
with increased IOP in POAG [31]. In an expression study on 
ocular tissues and human retina, predominant expression of 
TMCO1 was observed in the ciliary body, which is respon-
sible for producing the aqueous humor, and in the trabecular 
meshwork (TM), a crucial determinant of the IOP due to its 
resistance during the drainage of aqueous humor from the eye 
[32,33]. Therefore, TMCO1 might also be involved in regu-
lating IOP levels together with ciliary body and TM since the 
rs4656461 polymorphism is also associated with increased 
IOP in various studies [14,15,31].
No association of rs4977756 in CDKN2B-AS1, rs1063192 
in CDKN2B, and rs10483727 in SIX1 was observed. The 
results of the present study are surprisingly different from 
previous studies, in which a strong association for rs4977756 
was observed for Australian patients of European descent 
with POAG, and for rs1063192 in patients in the Afro-Carib-
bean population of Barbados with POAG. In a meta-analysis 
by Ramdas et al., which included data from six independent 
studies, a significant association of rs1063192 in CDKN2B 
and rs10483727 in SIX1 was observed with POAG [16]. Simi-
larly, in a GWAS by Burdon et al. rs4977756 in CDKN2B-AS1 
was highly associated with POAG [6]. Similar to our study, no 
association of rs10483727 in the SIX1 gene was observed in 
patients in the Afro-Caribbean population of Barbados with 
POAG, while strong association was observed in patients in 
a U.S. Caucasian population with POAG [34].
In conclusion, the results of the present study revealed 
that the TMCO1 rs4656461 SNP is significantly associated 
with glaucoma, irrespective of the type (POAG, PACG, 
PEXG). The ATOH7 rs1900004 polymorphism was protective 
for PACG in Pakistani patients, while the CAV1 rs4236601 
SNP conferred increased risk of POAG. Further replication 
studies of these polymorphisms in different types of glau-
coma in various populations are required, along with func-
tional studies to better understand the disease mechanisms.
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